{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T02:04:38Z","timestamp":1747101878939,"version":"3.37.3"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"JSPS KAKENHI","award":["19H03549"],"award-info":[{"award-number":["19H03549"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s13760-020-01592-z","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T10:03:13Z","timestamp":1610100193000},"page":"231-232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of phosphatidic acid on antiganglioside antibody reactivity in the isolated facial diplegia variant of Guillain\u2013Barr\u00e9 syndrome: a case report"],"prefix":"10.1007","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8931-8861","authenticated-orcid":false,"given":"Keiichi","family":"Nakahara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunya","family":"Nakane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"1592_CR1","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung HP (2012) Guillain\u2013Barr\u00e9 syndrome. N Engl J Med 366:2294\u20132304","journal-title":"N Engl J Med"},{"key":"1592_CR2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","volume":"10","author":"BR Wakerley","year":"2014","unstructured":"Wakerley BR, Unici A, Yuki N (2014) GBS classification group. Guillain\u2013Barr\u00e9 and Miller Fisher syndromes\u2014new diagnostic classification. Nat Rev Neurol 10:537\u2013544","journal-title":"Nat Rev Neurol"},{"key":"1592_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/014107689909200112","volume":"92","author":"EK Tan","year":"1999","unstructured":"Tan EK, Lim SH, Wong MC, Chan LL (1999) Facial diplegia: cranial variant of Guillain\u2013Barr\u00e9 syndrome? J R Soc Med 92:26\u201327","journal-title":"J R Soc Med"},{"key":"1592_CR4","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s00415-009-5254-8","volume":"256","author":"K Susuki","year":"2009","unstructured":"Susuki K, Koga M, Hirata K, Isogai E, Yuki N (2009) A Guillain\u2013Barr\u00e9 syndrome variant with prominent facial diplegia. J Neurol 256:1899\u20131905","journal-title":"J Neurol"},{"key":"1592_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/jns.12115","volume":"20","author":"JK Kim","year":"2015","unstructured":"Kim JK, Oh SY, Shon EH, Hong YH, Jun SM, Bae JS (2015) When is facial diplegia regarded as a variant of Guillain\u2013Barr\u00e9 syndrome? J Peripher Nerv Syst 20:32\u201336","journal-title":"J Peripher Nerv Syst"},{"key":"1592_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/mus.24887","volume":"52","author":"BR Wakerley","year":"2015","unstructured":"Wakerley BR, Yuki N (2015) Isolated facial diplegia in Guillain\u2013Barr\u00e9 syndrome: bifacial weakness with paresthesias. Muscle Nerve 52:927\u2013932","journal-title":"Muscle Nerve"},{"key":"1592_CR7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/mus.10307","volume":"27","author":"S Kusunoki","year":"2003","unstructured":"Kusunoki S, Morita D, Ohminami S, Hitoshi S, Kanazawa I (2003) Binding of immunoglobulin G antibodies in Guillain\u2013Barr\u00e9 syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications. Muscle Nerve 27:302\u2013306","journal-title":"Muscle Nerve"},{"key":"1592_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3988\/jcn.2014.10.2.94","volume":"10","author":"JK Kim","year":"2014","unstructured":"Kim JK, Bae JS, Kim DS, Kusunoki S, Kim JE, Kim JS et al (2014) Prevalence of anti-ganglioside antibodies and their clinical correlates with Guillain\u2013Barr\u00e9 syndrome in Korea: A Nationwide Multicenter Study. J Clin Neurol 10:94\u2013100","journal-title":"J Clin Neurol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01592-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-020-01592-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01592-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T09:43:51Z","timestamp":1676799831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-020-01592-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1592"],"URL":"https:\/\/doi.org\/10.1007\/s13760-020-01592-z","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"type":"print","value":"0300-9009"},{"type":"electronic","value":"2240-2993"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"assertion":[{"value":"14 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"To ensure confidentiality and anonymity of our patient, only clinical data are presented.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The patient has given his informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All data related to this case report are contained within the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}